US equities
|
SPCX
$175.24
▲+2.43%
NVDA
$242.19
▲+1.38%
MU
$1,062.46
▼-0.14%
MRVL
$291.82
▲+7.59%
AMD
$648.31
▲+2.62%
SNDK
$1,666.58
▼-2.21%
TSLA
$381.06
▲+0.61%
AVGO
$374.95
▲+3.43%
SPCX
$175.24
▲+2.43%
NVDA
$242.19
▲+1.38%
MU
$1,062.46
▼-0.14%
MRVL
$291.82
▲+7.59%
AMD
$648.31
▲+2.62%
SNDK
$1,666.58
▼-2.21%
TSLA
$381.06
▲+0.61%
AVGO
$374.95
▲+3.43%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
September 11, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
September 09, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
June 25, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
June 23, 2026
From
Quantum BioPharma Ltd.
Via
GlobeNewswire
Tickers
CSE:QNTM
QNTM